Cogent Biosciences (COGT) Net Equity Issued and Repurchased (2017 - 2025)

Cogent Biosciences (COGT) posted quarterly Net Equity Issued and Repurchased of $135.0 million for Q4 2025, up 455.56% quarter-over-quarter from $24.3 million in Q1 2025.

Cogent Biosciences (COGT) Net Equity Issued and Repurchased (2017 - 2025) Analysis & Trends

Cogent Biosciences (COGT) has reported Net Equity Issued and Repurchased for 6 consecutive years, with $135.0 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $135.0 million; the TTM figure through Dec 2025 stood at $159.3 million (down 1.55% YoY), while the FY2025 annual figure was $159.3 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased rose to $135.0 million in Q4 2025 per COGT's latest filing, from $24.3 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $161.8 million in Q2 2023 and bottomed at $24.3 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 141.90 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Cogent Biosciences 6.58 Bn 6.58 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 135.00 Mn
Dec 31, 2025 135.00 Mn
Mar 31, 2025 24.30 Mn
Mar 31, 2025 24.30 Mn
Jun 30, 2023 161.80 Mn
Jun 30, 2023 161.80 Mn
Dec 31, 2020 14.33 Mn
Dec 31, 2020 14.33 Mn
Sep 30, 2020 10.57 Mn
Sep 30, 2020 10.57 Mn
Jun 30, 2020 62,000.00
Jun 30, 2020 62,000.00
Mar 31, 2020 38,000.00
Mar 31, 2020 38,000.00
Jun 30, 2019 97,000.00
Jun 30, 2019 97,000.00
Mar 31, 2019 11,000.00
Mar 31, 2019 11,000.00
Dec 31, 2018 395,000.00
Dec 31, 2018 395,000.00